Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

cce3c732110ba85e5c720b2968bb007b96117ae5c235af302c2c15bddad2b009

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD, Per Share]

EPS - Diluted [USD, Per Share]

e464816929e99159ae47b2b18805a58d866bcff895037f748848b5357017fb5e

9d7be43b076bfbc8948cbe482aff0a2a80447da23daa96072ad16af1822ad59e

Unit Volume Growth for MedSurg and Neurotechnology (percentage)

Unit Volume Growth for Orthopaedics and Spine (percentage)

Unit Volume Growth (Consolidated) (percentage)

26a3120e8ad5f92fcd3c39b543e064054aa4d39232d9b197dab2111372572d4d

United States

International

- Europe, Middle East, Africa

- Asia Pacific

- Other countries

Total Revenue

1ec9107a8264422a371acab0f6a4bf09735ba207f64366f36007feb8c848e160

55f2c8003e6066c513a51f71978a59c0340abaf1d17808e481d1dcd68beefaf0

Cash and cash equivalents (USD, millions)

Short-term investments (USD, millions)

Marketable securities (USD, millions)

Accounts receivable, net (USD, millions)

Total inventories (USD, millions)

Prepaid expenses and other current assets (USD, millions)

Total current assets (USD, millions)

Property, plant and equipment, net (USD, millions)

Goodwill (USD, millions)

Other intangibles, net (USD, millions)

Noncurrent deferred income tax assets (USD, millions)

Other noncurrent assets (USD, millions)

Total assets (USD, millions)

Accounts payable (USD, millions)

Accrued compensation (USD, millions)

Income taxes, current liabilities (USD, millions)

Dividend payable (USD, millions)

Accrued expenses and other liabilities (USD, millions)

Current maturities of debt (USD, millions)

Total current liabilities (USD, millions)

Long-term debt, excluding current maturities (USD, millions)

Income taxes, noncurrent liabilities (USD, millions)

Other noncurrent liabilities (USD, millions)

Total liabilities (USD, millions)

Common stock (USD, millions)

Additional paid-in capital (USD, millions)

Retained earnings (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Total shareholders' equity (USD, millions)

Total liabilities & shareholders' equity (USD, millions)

0a086326b1a6b0726e1595bfc061f9613b30a05bb2a03bb3e0b42a14da194666

Net earnings (USD, millions)

Depreciation (USD, millions)

Amortization of intangible assets (USD, millions)

Goodwill and other impairments (USD, millions)

Asset impairments (USD, millions)

Share-based compensation (USD, millions)

Sale of inventory stepped up to fair value at acquisition (USD, millions)

Deferred income tax (benefit) expense (USD, millions)

Income taxes (USD, millions)

Other, net (USD, millions)

Net cash provided by operating activities (USD, millions)

Acquisitions, net of cash acquired (USD, millions)

Purchase of short-term investments (USD, millions)

Purchases of marketable securities (USD, millions)

Proceeds from sales of marketable securities (USD, millions)

Purchases of property, plant and equipment (USD, millions)

Proceeds from settlement of net investment hedges (USD, millions)

Other investing, net (USD, millions)

Net cash used in investing activities (USD, millions)

Proceeds (payments) on short-term borrowings, net (USD, millions)

Proceeds from issuance of long-term debt (USD, millions)

Payments on long-term debt (USD, millions)

Payments of dividends (USD, millions)

Cash paid for taxes from withheld shares (USD, millions)

Other financing, net (USD, millions)

Net cash provided by (used in) financing activities (USD, millions)

Effect of exchange rate changes on cash and cash equivalents (USD, millions)

Change in cash and cash equivalents (USD, millions)

Cash paid for income taxes, net of refunds (USD, millions)

Cash paid for interest on debt (USD, millions)

Accounts receivable (USD, millions)

Inventories (USD, millions)

Cash and cash equivalents at beginning of year (USD, millions)

Cash and cash equivalents at end of year (USD, millions)

84187042bcedf019715082eb8240f2166cdc899bf8477bf24639d67f781afd4b

Net Sales (USD, millions)

Cost of Sales (USD, millions)

Gross Profit (USD, millions)

Research, Development and Engineering Expenses (USD, millions)

Selling, General and Administrative Expenses (USD, millions)

Amortization of Intangible Assets (USD, millions)

Goodwill and Other Impairments (USD, millions)

Total Operating Expenses (USD, millions)

Operating Income (USD, millions)

Other Income (Expense), Net (USD, millions)

Earnings Before Income Taxes (USD, millions)

Income Taxes (USD, millions)

Net Earnings (USD, millions)

Net Earnings per Share of Common Stock - Basic (USD)

Net Earnings per Share of Common Stock - Diluted (USD)

ccf432d7b1ba7c1cc66907b4ffd78e2f2d8bfe3b2a274d1c14cf06234716f1a2

Stryker Corp (SYK)

Financials